Quarterly report · Q1
8086.TEDINET S100OZ7P
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥127.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥494.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.0bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥5.5bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥7.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.3bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥947.6bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥930.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥874.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥730.3bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥730.5bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥217.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥199.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥185.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥84.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥95.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥32.35 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.5 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.24 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.66 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.42 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥855m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.1bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥99.3bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥97.7bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.2bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.9bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥407m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥136.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥137.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥693m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥153m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥540m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | ¥145m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥5.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥92.2bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥90.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥9.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥21.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥16.4bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥12.4bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥10.8bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥844m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥117.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥118.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)ひびき監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)岡 田 博 憲 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中 須 賀 高 典 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)卜 部 陽 士 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 118001000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 127892000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 494789000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 5231000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 7337000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 27583000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 3300000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 5275000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 13455000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 15754000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 19483000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 31987000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 185923000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 217251000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 199867000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 874810000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 947561000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 930321000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 20.24 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 32.35 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 82.50 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 28.66 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 77.42 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.198 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.213 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.199 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 171459479 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 171459479 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 171459479 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 171459479 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7762700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1635948 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 163594800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 101979 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 171459479 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 1635948 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 7762700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7762700 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |